DCF Advisers’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,000
| Closed | -$1.1M | – | 92 |
|
|
2021
Q2 | $1.1M | Sell |
6,000
-6,000
| -50% | -$1.1M | 0.39% | 39 |
|
|
2021
Q1 | $1.84M | Sell |
12,000
-3,000
| -20% | -$459K | 0.8% | 27 |
|
|
2020
Q4 | $2.34M | Buy |
15,000
+2,000
| +15% | +$313K | 0.97% | 28 |
|
|
2020
Q3 | $1.49M | Hold |
13,000
| – | – | 0.76% | 28 |
|
|
2020
Q2 | $1.46M | Buy |
13,000
+4,000
| +44% | +$449K | 0.82% | 29 |
|
|
2020
Q1 | $808K | Buy |
+9,000
| New | +$808K | 0.53% | 32 |
|